Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 16.52 is 73% above its 3-year average of 9.55, near the high end of its 3-year range (0.00–22.91).
As of the fiscal period ended Tuesday, June 30, 2026. 6.54% above its 12-month average of 15.51.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 16.52.
CURRENT RATIO
16.52
CURRENT RATIO AVG TTM
15.51
CURRENT RATIO AVG 3Y
10.50
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+6.54%
CURRENT VS 3Y AVG
+57.31%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+340.60%
vs the sector median at left
MapLight Therapeutics, Inc.
Market Cap
$412.91M
Current Ratio
16.52
TTM Avg
15.51
3Y Avg
10.50
5Y Avg
N/A
Market Cap
$411.43M
Current Ratio
2.64
TTM Avg
6.72
3Y Avg
6.86
5Y Avg
10.11
Market Cap
$409.29M
Current Ratio
9.89
TTM Avg
6.34
3Y Avg
6.34
5Y Avg
6.34
Market Cap
$417.78M
Current Ratio
25.05
TTM Avg
8.87
3Y Avg
10.83
5Y Avg
12.06
Market Cap
$417.94M
Current Ratio
6.74
TTM Avg
3.59
3Y Avg
4.96
5Y Avg
4.92
Market Cap
$405.46M
Current Ratio
8.13
TTM Avg
16.34
3Y Avg
21.67
5Y Avg
17.16
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | $412.91M | 16.52 | 15.51 | 10.50 | N/A |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.43M | 2.64 | 6.72 | 6.86 | 10.11 |
| Rezolute, Inc. (RZLT)vs › | $409.39M | 9.44 | 11.90 | 14.34 | 23.42 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $409.29M | 9.89 | 6.34 | 6.34 | 6.34 |
| Prothena Corporation plc (PRTA)vs › | $417.78M | 25.05 | 8.87 | 10.83 | 12.06 |
| Editas Medicine, Inc. (EDIT)vs › | $419.18M | 3.19 | 3.65 | 4.66 | 6.11 |
| Senseonics Holdings, Inc. (SENS)vs › | $417.94M | 6.74 | 3.59 | 4.96 | 4.92 |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $405.46M | 8.13 | 16.34 | 21.67 | 17.16 |
| Myriad Genetics, Inc. (MYGN)vs › | $403.77M | 2.21 | 2.16 | 2.08 | 2.23 |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $423.41M | 3.48 | 10.77 | 42.35 | 30.00 |
Current Ratio
16.52
Quick Ratio
16.52
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 16.52 |
| 2026-03-31 | 22.91 |
| 2025-12-31 | 20.01 |
| 2025-09-30 | 13.22 |
| 2025-06-30 | 4.89 |
| 2025-03-31 | 7.57 |
| 2024-12-31 | 7.20 |
| 2024-09-30 | 0.00 |
| 2024-06-30 | 0.00 |
| 2024-03-31 | 12.72 |
| 2023-03-31 | 0.00 |
